What this site does
GLPOneReview reviews the GLP-1 telehealth programs people search for by name. Each review is built from the program's own pages, read on a stated date: price and billing basis, membership, what is included, pharmacy, prescriber, cancellation and refunds. Clinical pages summarize FDA labels and published trials.
How the site is funded
GLPOneReview is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. NexLife, our editorial pick, is an affiliate relationship; links to NexLife carry tracking parameters. Public-facing NexLife links carry UTM tracking for referral measurement. Every program we track stays in our tables with its dated price.
Earlier versions of this site described it as "editorially independent". We removed that description on November 8, 2026 because it did not disclose the commercial relationship with NexLife; see corrections and conflicts of interest.
Who is behind it
Publisher: GLPOneReview. Research: Dr. Parmis. Medical review: Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). See the team page. Contact: editor@glponereview.com.
Dates
The first version of the site on record is dated May 8, 2026. Each page shows its own release date and the date it was last reviewed; prices show the date they were read. This update is dated November 8, 2026.
How we rank
We rank programs by the computed transparency index described in the methodology; NexLife meets 5 of 6 checks on reads of November 20 and 21, 2026 and is also our editor's pick, an editorial selection. The fixed 94/100 score shown from November 8, 2026 is withdrawn.